Independent research site — not a government website and not affiliated with any agency. Official program information and applications are always free from the agency. Learn more

Gov Funds FinderFree screening

Forecasted · Grant

Exposomic Contributions to ADRD Pathology and Resilience

National Institutes of Health, Department of Health and Human Services

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name
Exposomic Contributions to ADRD Pathology and Resilience
Issuing agency
National Institutes of Health (Department of Health and Human Services)
Opportunity number
RFA-NS-26-031
Funding type
Grant
Funding purpose
Health
Status
Forecasted
Application deadline
Forecasted · estimated close October 5, 2026 (agency estimate)
Agency estimates
Estimated posting: July 1, 2026. Estimated award date: June 1, 2027. Estimates can change.
Published award range
Not published by the agency
Cost sharing or match required
No
Eligible applicants (official categories)
  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • Private institutions of higher education
  • For profit organizations other than small businesses
  • Small businesses
  • Others (see Additional Information on Eligibility)
Relevant to
Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
Geographic restrictions
None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
Assistance Listing (CFDA)
93.853
Official source
View on Grants.gov ↗
Application URL
www.grants.gov/search-results-detail/361451 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
Source identifier
Grants.gov opportunity ID 361451 · Funding opportunity number RFA-NS-26-031
Posted
March 11, 2026 · Source last updated March 11, 2026
Last verified
October 29, 2026 (against Grants.gov)
Data completeness
92% of key fields published by the sourceNot published: published funding range.
Record confidence
mediumforecast — dates and amounts are agency estimates.

Eligibility details (from the agency)

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Description (from the official listing)

The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects that investigate how specific neural exposome factors contribute mechanistically to Alzheimer’s disease-related dementias (ADRD) pathology and resilience. For the purposes of this program, exposome factors of interest include, but are not limited to, environmental toxins, sleep and circadian rhythms, stress, and the real-world conditions that modulate them (e.g., light, noise, heat).Applications will be expected to propose research on the synergistic action between multiple exposome factors, and the composite effects of mixtures of exposome factors on neural mechanisms relevant to ADRD. Applicants are encouraged to focus on mechanistic pathways (e.g., microbiome–brain interactions, neuroimmune signaling, epigenetic modifications) that link exposures to ADRD risk, progression, and resilience. Applicants are further encouraged to consider studies that cover the lifespan, including work that investigates critical or sensitive periods of exposure or factors that may lead to neurological health disparities. Applicants may propose mechanistic, translational, and/or human subjects research, drawing on clinical data, human samples, and observational or interventional studies. However, NIH-defined clinical trials will not be supported under this program.Applications are not currently being solicited. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigative teams with expertise in…

Read the full description

The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects that investigate how specific neural exposome factors contribute mechanistically to Alzheimer’s disease-related dementias (ADRD) pathology and resilience. For the purposes of this program, exposome factors of interest include, but are not limited to, environmental toxins, sleep and circadian rhythms, stress, and the real-world conditions that modulate them (e.g., light, noise, heat).Applications will be expected to propose research on the synergistic action between multiple exposome factors, and the composite effects of mixtures of exposome factors on neural mechanisms relevant to ADRD. Applicants are encouraged to focus on mechanistic pathways (e.g., microbiome–brain interactions, neuroimmune signaling, epigenetic modifications) that link exposures to ADRD risk, progression, and resilience. Applicants are further encouraged to consider studies that cover the lifespan, including work that investigates critical or sensitive periods of exposure or factors that may lead to neurological health disparities. Applicants may propose mechanistic, translational, and/or human subjects research, drawing on clinical data, human samples, and observational or interventional studies. However, NIH-defined clinical trials will not be supported under this program.Applications are not currently being solicited. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigative teams with expertise in exposomics and environmental neuroscience, community engagement, ADRD mechanisms, and non-medical factors that may lead to health disparities are encouraged to apply.

Agency contact

NINDS Office of Neural Exposome and Toxicology and NINDS Office of Global Health and Health Disparities
NINDSONETOX@ninds.nih.gov

Report an error or outdated information on this page

Related opportunities

ForecastedGrantNonprofits

Innovative Approaches for Reducing Disparities in Kidney Health

Office of the Assistant Secretary for Health · Department of Health and Human Services · MP-CPI-25-002

Deadline
Forecasted · estimated close February 11, 2025 (agency estimate)
Published award range
Published award: $425,000 – $500,000
ForecastedGrantNonprofits

Making America Healthy Again by Addressing Dementia Disparities

Office of the Assistant Secretary for Health · Department of Health and Human Services · MP-CPI-25-001

Deadline
Forecasted · estimated close June 23, 2025 (agency estimate)
Published award range
Published award: $450,000 – $600,000
ForecastedGrantNonprofits

Coordinating Center for Language Access Services

Office of the Assistant Secretary for Health · Department of Health and Human Services · MP-CPI-25-003

Deadline
Forecasted · estimated close July 1, 2025 (agency estimate)
Published award range
Published award: $600,000 – $700,000
ForecastedGrantNonprofits

Promoting Access with a Language Services Assistance Symbol

Office of the Assistant Secretary for Health · Department of Health and Human Services · MP-CPI-25-004

Deadline
Forecasted · estimated close July 2, 2025 (agency estimate)
Published award range
Published award: $500,000 – $600,000